Introduction {#sec1}
============

Cellular senescence can be induced by telomere shortening, which causes irreversible cell cycle arrest.^[@ref1]^ This mechanism plays an important role in aging, tumor suppression, and developing tumors.^[@ref2]^ Numerous reports have documented that oxidative stress and oncogenes can induce stress-induced premature senescence (SIPS) in tumor cells, which differs from replicative senescence, known as passaging.^[@ref3]^ Reactive oxygen species (ROS), such as the superoxide anion (O~2~^--^), hydroxyl radical (OH^•^), and hydrogen peroxide (H~2~O~2~), despite being intracellular signals and growth stimulants, are well-known triggers of senescence.^[@ref4],[@ref5]^ In particular, H~2~O~2~ is widely used as an exogenous inducer of cellular senescence. Excess oxidative stress induced by H~2~O~2~ produces oxidative damage to DNA, which promotes SIPS in tumor cells.^[@ref6]^ This generally results in a distinct morphology change, gene expression pattern, and secretory phenotype. The most common feature is the increased activity of the senescence-associated β-galactosidase in the G1 phase of the cell cycle.^[@ref7],[@ref8]^ The antineoplastic drugs, such as cisplatin and doxorubicin (Dox), have been used to treat several human cancers because they trigger ROS-induced apoptosis, senescence, and DNA damage.^[@ref9],[@ref10]^ However, escape from senescence would result in cancer cell repopulation and treatment resistance. Therefore, the identification of the senescence state is necessary to improve the response to anticancer therapy. Accordingly, the development of ratiometric fluorescent probes to monitor the concentration of ROS and β-galactosidase activity in living cells is needed to detect SIPS.

Recently, many β-galactosidase-targeting fluorescent probes have been developed to detect senescent cells.^[@ref11]^ The traditional analyte, X-Gal (5-bromo-4-chloro-3indolyl-β-[d]{.smallcaps}-galactoside), is widely used for chromogenic staining β-galactosidase activity in fixed cells or tissues.^[@ref12]^ Urano developed a series of rhodamine-derived probes for the detection of β-galactosidase in cultured cells and *Drosophila melanogaster* tissue with LacZ(+) that encodes *Escherichia coli* β-galactosidase activity.^[@ref13],[@ref14]^ Recently, Cui and co-workers achieved in vivo imaging of DNA damage-induced senescence using a near-infrared fluorescent probe.^[@ref15]^ However, the usage of fluorescent probes has not been appropriately studied for the ratiometric detection of the senescence-associated β-galactosidase activity induced by the ROS in living cancer cells. Typically, the ROS level is elevated in the case of almost all cancers and is linked to tumor development and progression.^[@ref16],[@ref17]^ These cancer cells display increased levels of β-galactosidase, suggesting that monitoring the degree of altered levels of β-galactosidase activity and senescence-associated cellular changes that are induced by additional ROS is required.

In this study, we designed and synthesized simple and robust fluorescent probes to monitor oxidative stress and β-galactosidase activity for the detection of SIPS ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}A). 2-(2′-Hydroxyphenyl)benzothiazole (HBT), despite being a small organic molecule, is a commonly used fluorophore with attractive properties, including a four-level photochemical process and a large Stokes shift as well as solubility in aqueous media, compared to those of conventional fluorophores such as fluorescein and boron dipyrromethene. This luminescence mechanism is based on the excited-state intramolecular proton transfer (ESIPT). Typically, the ESIPT fluorophores exist in an enol form in the ground state (N). Upon photoexcitation, they exhibit a dual-emission process with the tautomeric form (T\*) from the normal form (N\*). The excited enol form rapidly undergoes ESIPT conversion to its excited keto form. After decaying in keto emission, the ground state keto tautomer (T) undergoes retro proton transfer to ensure the regeneration of the initial enol form. Because of this photochemical process, which reduces the inner filter effect, the ESIPT-based fluorescent probes can be used as imaging agents.^[@ref18]^ Although some of the ESIPT-based fluorescent probes have allowed the determination of the ROS and β-galactosidase activity, a suitable fluorescent probe is still needed for imaging the SIPS in tumor cells.^[@ref19]−[@ref24]^ We prepared some phenylboronic acid derivatives, as shown in [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}B. Among them, (2-(benzo\[*d*\]thiazol-2-yl)phenyl)boronic acid (BTPB) **1a** exhibited sensitivity toward ROS subsets, such as hydroxyl radical (OH^•^), superoxide radical (O~2~^•--^), and H~2~O~2~, and it was successfully applied for imaging of cellular ROS in living cells with high contrast. A 2-(4′-chloro-2′-hydroxyphenyl)benzothiazole (CBT)-based enzymatically turn-on probe (CBT-β-Gal) **4** was designed, synthesized, and used to detect the increased level of the β-galactosidase activity in the HeLa cells. CBT-β-Gal exhibited enhanced fluorescence intensity in H~2~O~2~-treated cells when compared with H~2~O~2~-untreated cells, and the fluorescence increased with increasing H~2~O~2~ concentration. In addition, these probes could be used to stain the ROS and β-galactosidase activity in the doxorubicin-treated HeLa cells.

![(A) Mechanism of the ESIPT process. (B) Chemical structures of **1a** and CBT-β-Gal **4** and the principle of ESIPT-based fluorescence for the detection of H~2~O~2~ or doxorubicin-induced cellular senescence.](ao9b04208_0001){#fig1}

Results and Discussion {#sec2}
======================

Because of the photostability in aqueous solution and lack of autofluorescence background, the HBT fluorophore is more advantageous for bioimaging when compared with the conventional fluorescent agents. Otsubo et al. synthesized ESIPT-based HBT derivatives exhibiting a large Stokes shift (approximately 150 nm).^[@ref25]^ They determined that the HBT substituent pattern shifted the fluorescence wavelength. Inspired by their work, we designed HBT-based probes, BTPB derivatives, for H~2~O~2~ detection via the oxidation reaction of the arylboronic acids to transform into the fluorescent phenol. Arylboronic acids **1a--f** with substitutes, such as chlorine, fluorine, and methoxy groups at the phenyl ring, were synthesized according to the reported procedures ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). To confirm their capability to detect H~2~O~2~, we measured the time-dependent fluorescence intensities of **1a--f** (100 μM) after the addition of H~2~O~2~ (1 mM) for 2 h. The fluorescence intensity was recorded at 510 nm with 356 nm excitation using a multiplate reader ([Figure S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b04208/suppl_file/ao9b04208_si_001.pdf)).

![Synthesis of the (2-(Benzo\[*d*\]thiazol-2-yl)phenyl)boronic Acid Derivatives](ao9b04208_0009){#sch1}

The fluorescence intensities of **1a** without a substitute and **1b** with a chlorine atom increased by 30 times in 2 h upon the addition of H~2~O~2~. **1c** with a fluorine atom did not present adequate enhanced fluorescence. When **1d** and **1e** with a methoxy group were evaluated upon the addition of H~2~O~2~, the electron-donating effect caused a longer shift in fluorescence wavelength when compared with that observed in **1a**. Unfortunately, these probes were not suitable for imaging because of their poor solubility in aqueous media. However, **1f** exhibited strong fluorescence with absorption at 365 nm. These results implied that probe **1a** could rapidly detect H~2~O~2~ and provide bright fluorescence for imaging. Subsequently, we examined the cytotoxicity of probe **1a** using a standard cell viability assay, i.e., the WST-1 assay. As presented in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}, the HeLa cells treated with concentrations of up to 50 μM of probe **1a** exhibited similar viability as that exhibited by the untreated cells.

![Cytotoxicity of probe **1a**. The HeLa cells were treated with probe **1a** for 24 h, and the cell viability was determined using the WST-1 assay. Data shown is an average ± SD.](ao9b04208_0002){#fig2}

The photophysical properties of probe **1a** were assessed in the presence of H~2~O~2~ in phosphate-buffered saline (PBS) buffer ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}a). The solution of probe **1a** emitted a weak fluorescence (λ~em~ = 458 nm, Φ = 0.02) in the presence of H~2~O~2~. The reaction of **1a** with H~2~O~2~ undergoes conversion to the fluorescent phenol, HBT, via *ipso*-oxidation. The fluorescence emission was gradually red-shifted (λ~em~ = 510 nm) and steadily increased upon exposure to H~2~O~2~ (for a period of 2 h). After 2 h, the absolute quantum yield increased to 0.21 ([Figure S4A](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b04208/suppl_file/ao9b04208_si_001.pdf)). The UV--vis absorption and fluorescence spectra of the fluorophore HBT were measured using a PBS buffer (pH 7.0). The major absorption band was at 359 nm (ε = 3178 M^--1^ cm^--1^), and the fluorescence maximum wavelength emitted at 510 nm (Φ = 0.32) had a large Stokes shift of 151 nm. Next, we evaluated the fluorescent wavelengths of the PBS solutions having different pH values (6.0, 6.4, 7.0, 7.4, and 8.0) ([Figure S3 and Table S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b04208/suppl_file/ao9b04208_si_001.pdf)). HBT was protonated to the keto form in a slightly acidic solution (pH 6.0 and 6.4), increasing the fluorescence emission at approximately 510 nm via the ESIPT process. At pH 7.0, blue and green signals could be observed. Blue fluorescence was mainly observed through enol emission in the case of physiological pH values (pH 7.4) and weak basic conditions (pH 8.0). Similarly, we analyzed the UV--vis absorption and fluorescence spectra of the fluorophore 2-(4′-chloro-2′-hydroxyphenyl)benzothiazole (CBT) relative to **1b**. CBT exhibited useful photophysical properties (λ~em~ = 508 nm, Φ = 0.36, and ε = 3635 M^--1^ cm^--1^) in the case of biological imaging.

To examine the selectivity of **1a** for biologically relevant ROS, the fluorescence change was measured in the presence of H~2~O~2~, hypochlorite (ClO^--^), *tert*-butylhydroperoxide (*t*BHP), nitrite (NO~2~^--^), *tert*-butyl radical (^•^O*t*Bu), hydroxyl radicals (^•^OH), and superoxide (O~2~^--^) ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}B). Among the ROS species, probe **1a** exhibited selectivity for ROS subsets, such as H~2~O~2~, hydroxyl radicals (^•^OH), and superoxide (O~2~^--^), according to the significantly enhanced fluorescence intensity. These results suggested that **1a** acts as a ratiometric fluorescent probe not only for H~2~O~2~ but also for ^•^OH and O~2~^--^.

![(A) Fluorescence spectra change of probe **1a** (100  μM) after the addition of H~2~O~2~ (1  mM) in PBS buffer (pH = 7.0) (λ~ex~ = 365  nm, steady excitation). Time points are 0, 5, 10, 15, 20, 30, 60, and 120 min after the addition of H~2~O~2~. (B) Fluorescence spectra change of probe **1a** (50  μM) in response to ROS species (20 equiv) for 120  min in PBS (pH = 7.0, λ~ex~ = 365  nm, λ~em~ = 510  nm).](ao9b04208_0003){#fig3}

We examined the capability of probe **1a** to detect H~2~O~2~ in the HeLa cells as a model of cell lines ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}). After incubation with **1a** (50 μM) for 30 min, the cells were treated with H~2~O~2~ (200 or 400 μM) for 30 min. The imaging at an excitation with 365 nm showed enhanced fluorescence intensity in the blue channel. Imaging with **1a** in the blue channel was sharper than that in the green channel. We observed a significantly enhanced fluorescence intensity for the cells cultured in the presence of H~2~O~2~. The fluorescence intensity was brighter for 400 μM H~2~O~2~ treatment than for 200 μM ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}A). The fluorescence intensity was enhanced by up to approximately 7 times in cells treated with 400 μM H~2~O~2~ when compared with that in untreated cells. Fluorescence imaging was unsuccessful because of the poor solubility of probe **1b**. We further performed the detection of endogenous ROS in HeLa cells that were incubated with probe **1a** for 24 h (details are shown in [Figure S7](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b04208/suppl_file/ao9b04208_si_001.pdf)). We observed increased blue fluorescence to detect cellular ROS in living cells. Thus, probe **1a** could image the cellular accumulation of ROS.

![(A) Images of the HeLa cells loaded with probe **1a** (50  μM) after treatment with H~2~O~2~ (200 or 400  μM) for 30 min. Cell fluorescence imaging was performed by excitation at 365 nm, and emission was collected in green (500--550 nm) and blue (435--485  nm) channels. (B) Quantification of the fluorescence in the HeLa cells in the blue channel for the experiment shown in (A). The results are given as mean ± SD.](ao9b04208_0004){#fig4}

Otsubo et al. developed 2-(benzothiazol-2-yl)-phenyl-β-[d]{.smallcaps}-galactopyranoside (BT-β-Gal) derivatives, which can be used to assay the β-galactosidase activity.^[@ref25]^ We evaluated the potential of BT-β-Gal without a substitute to monitor the H~2~O~2~-induced β-galactosidase activity in the HeLa cells. However, an effective fluorescence signal was not recorded. We next designed the 2-(4′-chloro-2′-hydroxyphenyl)benzothiazole (CBT)-based enzymatic turn-on probe, (CBT-β-Gal) **4**. The synthetic route toward CBT-β-Gal **4** is illustrated ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). CBT **2** was synthesized by condensation of 4-chlorosalicylaldehyde with 2-aminobenzmide according to the reported procedures. The sequential reaction of CBT with 2,3,4,6-tetra-*O*-acetyl-α-[d]{.smallcaps}-galactopyranosyl bromide produced the corresponding product **3** in a 70% yield. The hydrolysis of acetyl esters produced CBT-β-Gal.

![Synthesis of CBT-β-Gal **4**](ao9b04208_0010){#sch2}

The cytotoxicity of CBT-β-Gal **4** was evaluated using the WST-1 assay ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}). The results revealed that CBT-β-Gal **4** concentrations of 25 μM had a cytotoxic effect on HeLa cells, suggesting that CBT-β-Gal **4** should be used for bioimaging at concentrations lower than 25 μM.

![Cytotoxicity of CBT-β-Gal **4**. The viability of HeLa cells treated with probe CBT-β-Gal for 24 h was evaluated by the WST-1 assay. The data shown is mean ± SD.](ao9b04208_0005){#fig5}

To confirm the capability of CBT-β-Gal **4** to detect β-galactosidase activity, we measured the time-dependent fluorescence intensity after the addition of β-galactosidase (20 U mL^--1^) for 20 min with 356 nm excitation ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}). As a result, CBT-β-Gal **4** emitted extremely weak fluorescence (Φ = 0.045), then the fluorescence intensity of **4** upon the addition of β-galactosidase significantly increased within 15 min. β-Galactosidase catalyzed the hydrolysis of β-galactopyranoside from CBT-β-Gal **4** and released fluorescent CBT (λ~em~ = 508 nm, Φ = 0.339) ([Figure S4B](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b04208/suppl_file/ao9b04208_si_001.pdf)). Hence, probe **4** achieved rapid detection for β-galactosidase activity.

![Fluorescence spectra change of CBT-β-Gal **4** (10  μM) upon addition of β-galactosidase (20  U mL^--1^) in PBS buffer (pH = 7.0) (λ~ex~ = 365  nm, steady excitation) at 0, 5, 10, 15, and 20  min time points after the addition of β-galactosidase.](ao9b04208_0006){#fig6}

Upon exposure of cancer cells to H~2~O~2~, the oxidative stress induces cellular senescence and elevated β-galactosidase activity is used as a biomarker of this phenotype. However, because the ROS level usually increases in almost all cancers, the HeLa cells also display detectable levels of β-galactosidase. To determine premature senescence in response to oxidative stress, the degree of altered levels of β-galactosidase activity compared to untreated cells is of importance. After the HeLa cells are stimulated by exposure to H~2~O~2~ for 2 h, followed by culturing for 24 h, they undergo senescence and become β-galactosidase-positive. Initially, we performed β-galactosidase detection using SPiDER-βGal, which is a fluorogenic β-galactosidase detection kit for staining the senescence-associated β-galactosidase in cells.^[@ref26]^ The results showed strong fluorescence even when the cells were not exposed to oxidative stress ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}A). Decreased fluorescence was observed after treatment using H~2~O~2~ (400 μM). Subsequently, we measured the fluorescence intensity of the HeLa cells cultured using CBT-β-Gal **4** after exposing them to H~2~O~2~ and without H~2~O~2~ exposure ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}B). After being treated with H~2~O~2~ (100, 200, and 400 μM) for 2 h, the cells cultured in the presence of CBT-β-Gal **4** for 24 h emitted blue fluorescence. The fluorescence intensity depended on the H~2~O~2~ dose, and it was enhanced by up to approximately 3.5 times in cells treated with H~2~O~2~ (400 μM). The cytoplasm was stained in the blue channel when subjected to bioimaging with CBT-β-Gal. Although the signal was weak in the green channel, this might be able to detect acid lysosomal β-Gal. The change in cell morphology because of cellular senescence is characterized by an enlarged, flattened, and irregular shape.^[@ref27]^ These morphological changes were observed in many cells after the treatment using H~2~O~2~ ([Figure S9](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b04208/suppl_file/ao9b04208_si_001.pdf)). In addition, we observed the morphological phenotype of apoptosis, such as nuclear condensation and cellular shrinkage, in the HeLa cells, as previously reported.^[@ref28]^ These results imply that CBT-β-Gal **4** can be useful to detect senescence in response to oxidative stress.

![(A) Images of the HeLa cells cultured with SPiDER-βGal (1.0 μM) after H~2~O~2~ treatment. (B) Images of the HeLa cells cultured with CBT-β-Gal **4** (12.5  μM) after H~2~O~2~ treatment. (C) Quantification of the fluorescence in the HeLa cells in the blue channel for the experiment shown in (B). The results are given as mean ± SD.](ao9b04208_0007){#fig7}

Finally, probes **1a** and CBT-β-Gal **4** could be applied to the imaging of the DNA damage-induced senescence. The antineoplastic drugs, such as doxorubicin, can cause apoptosis and senescence by damaging the DNA, which results in the production of ROS and the expression of β-galactosidase. We attempted to stain the ROS production and β-galactosidase activity in the Dox-treated cells ([Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}). Dox (100 nM) was added to the HeLa cells and cultured for 24 h. The cells showed bright fluorescence in the blue channel when compared with the Dox-untreated cells. These results indicate that Dox treatment induced the production of ROS and increased the β-galactosidase activity. Among these cells, enlarged senescent cells could be observed ([Figure S10](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b04208/suppl_file/ao9b04208_si_001.pdf)). In addition, SPiDER-βGal was used for imaging the β-galactosidase activity in the Dox-treated cells. The results obtained using CBT-β-Gal **4** are similar to those observed using the control probe SPiDER-βGal, denoting the sensitivity of CBT-β-Gal **4** in the case of the Dox-treated cells. Therefore, our probes **1a** and **4** can be used to monitor and image ROS and β-galactosidase in response to the Dox-induced DNA damage.

![Images of the HeLa cells treated using probe **1a** (50 μM), CBT-β-Gal (12.5 μM), and SPiDER-βGal (1.0 μM) after treatment with doxorubicin (100 nM) for 1 day. Images for probe **1a** and CBT-β-Gal were captured using the blue channel, whereas the red channel was used for imaging SPiDER-βGal.](ao9b04208_0008){#fig8}

Conclusions {#sec3}
===========

We developed two ESIPT-based fluorescent probes, **1a** and CBT-β-Gal **4**, to detect H~2~O~2~ and β-galactosidase activity. These probes exhibited a large Stokes shift and pH sensitivity and could be used in several biological applications. Probe **1a** could image the accumulation of ROS, which can induce cellular senescence. In addition, CBT-β-Gal **4** exhibited a good staining capability for β-galactosidase activity. We detected the increased β-galactosidase activity upon exposure of the HeLa cells to H~2~O~2~. Furthermore, we demonstrated the detection of ROS and β-galactosidase activity in the Dox-treated HeLa cells. Our study will be helpful in advancing the understanding of the process of aging, cellular senescence, tumor suppression, tumor development, and monitoring drug response in cancer therapies.

Experimental Section {#sec4}
====================

Instruments and Materials {#sec4.1}
-------------------------

All NMR spectra were recorded on Varian 500PS spectrometers. ^1^H and ^13^C NMR spectra are reported as chemical shifts (δ) in parts per million (ppm) relative to the solvent peak using tetramethylsilane (^1^H and ^13^C) as an internal standard. Chemical shifts (δ) are reported in parts per million (ppm), and coupling constants (*J*) were measured in hertz (Hz). NMR spectra were processed in ACD/SpecManager. High-resolution mass spectra (HRMS, *m*/*z*) were obtained on a JEOL JMS-700N for FAB using *m*-nitrobenzyl alcohol as the matrix or on a JEOL JMS-T100TD for electrospray ionization (ESI+). All reactions were performed in an apparatus with magnetic stirring in an inert atmosphere. Flash column chromatography was performed on a Silica Gel C60 (50--200 μm), Fuji Silysia Chemical Ltd., using an eluent system, as described in the experimental procedures. Thin-layer chromatography (TLC) was performed using TLC Silica Gel 60 F254 aluminum sheets (Merck). UV--visible spectra were measured using a Shimadzu RF-1500 spectrophotometer. The fluorescence intensity was recorded on a multiplate reader, BioTek Cytation 3. Fluorescence microscopy imaging was captured using a Keyence BZ-X710 with 20 or 40 objective lenses using the excitation wavelength of 340--380 nm, and the emission collected by the blue channel (435--485 nm) and the green channel (500--550 nm). Luminescence quantum yields of the compounds were recorded on a Hamamatsu Photonics Absolute PL quantum yield spectrometer (C9920-02G). For chemical experiments, general chemicals and solvents, arylboronic acid probes, 2-aminobenzenthiol, 2,3,4,6-tetra-*O*-acetyl-α-[d]{.smallcaps}-galactopyranosyl bromide, β-galactosidase from *Escherichia coli* (Grade VI, lyophilized powder, 250--600 units mg^--1^ protein), doxorubicin, SPiDER-βGal, MeOH, and acetonitrile were purchased from Tokyo Chemical Industries, Fujifilm Wako Pure Chemical, and Sigma-Aldrich Co., Ltd. Unless otherwise stated, all materials and reagents were obtained from commercial suppliers and used without further purification. For biological experiments, hydrogen peroxide (H~2~O~2~) solution (30% w w^--1^) was purchased from Fujifilm Wako Pure Chemical Co., Ltd. H~2~O~2~ was added by bath application to the medium from a 100 mM aqueous stock (super pure H~2~O). The HeLa cells were maintained in Eagle's minimum essential medium (MEM) purchased from Wako Pure Chemical Industries, Ltd. (Japan), supplemented with 5% fetal bovine serum from Life Technologies (Australia) and 100 unit mL^--1^ penicillin and 100 μg mL^--1^ streptomycin (Penicillin--Streptomycin mixed, Nacalai Tesque Inc., Japan) at 37 °C in 5% CO~2~. The cells were then kept in an incubator (37 °C, 5% CO~2~) during the course of the experiments.

General Synthesis Procedure for 1a--f {#sec4.2}
-------------------------------------

We synthesized arylboronic acids **1a--f** according to the literature.^[@ref29]^ 2-Formylphenylboronic acid (1.0 mmol) was added to a solution of 2-aminobenzenthiol (107 μL, 1.0 mmol) in MeOH (5.0 mL), and the reaction mixture was stirred at room temperature in open air for 24 h. The organic solvent was then evaporated, and the residue was purified by column chromatography (DCM/MeOH = 9:1); then, the products were recrystallized from dichloromethane (DCM) and methanol (MeOH) to obtain pure products in good yield. The characterization data and experimental procedure are shown in the Supporting Information ([SI](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b04208/suppl_file/ao9b04208_si_001.pdf)).

Synthesis of (2-(Benzo\[*d*\]thiazol-2-yl)phenyl)boronic Acid (BTPB) {#sec4.3}
--------------------------------------------------------------------

BTPB was prepared according to the general procedure using 2-formylphenylboronic acid (150 mg, 1.0 mmol) and 2-aminobenzenthiol (107 μL, 1.0 mmol) to produce product **1a** in a 67% yield. The NMR data of **1a** are consistent with the previous report.^[@ref29]1^H NMR (500 MHz, CD~3~OD) δ 7.44--7.58 (m, 6H), 7.83--7.86 (m, 1H), 8.01 (d, *J* = 6.4 Hz, 2H); ^13^C NMR (125 MHz, CD~3~OD) δ 121.2, 122.3, 125.5, 125.8, 126.9, 128.6, 130.7, 131.0, 134.6, 135.0, 149.9, 170.5; HRMS (FAB) *m*/*z* calcd for C~13~H~10~BNO~2~S \[M\]^+^ 255.0525, found 255.0522.

Synthesis of Fluorescent Probe CBT-β-Gal (**4**) {#sec4.4}
------------------------------------------------

### 2-(4′-Chloro-2′-hydroxyphenyl)benzothiazole (**2**) {#sec4.4.1}

4-Chlorosalicylaldehyde (470 mg, 3 mmol) was added to a solution of 2-aminobenzenthiol (314 μL, 3.0 mmol) in EtOH (15 mL), and the reaction mixture was stirred at room temperature in open air for 24 h. The organic solvent was then evaporated, and the residue was purified by column chromatography (AcOEt/*n*-hexane = 1:99) to obtain product **2** in a 63% yield. ^1^H NMR (500 MHz, CDCl~3~) δ 6.94 (dd, *J* = 2.2, 8.6 Hz, 1H), 7.12 (d, *J* = 2.0 Hz, 1H), 7.41--7.44 (m, 1H), 7.51--7.54 (m, 1H), 7.61 (d, *J* = 8.6 Hz, 1H), 7.91 (d, *J* = 7.8 Hz, 1H), 7.99 (d, *J* = 8.1 Hz, 1H), 12.7 (s, O*H*); ^13^C NMR (125 MHz, CDCl~3~) δ 115.5, 118.0, 120.0, 121.5, 122.2, 125.8, 126.9, 129.2, 132.4, 138.2, 151.6, 158.6 168.4; HRMS (FAB) *m*/*z* calcd for C~13~H~8~ClNOS \[M + H\]^+^ 262.0093, found 262.0093.

### Compound (**3**) {#sec4.4.2}

A solution of 2-(benzo\[*d*\]thiazol-2-yl)-5-chlorophenol (**2**) (105 mg, 0.4 mmol), 2,3,4,6-tetra-*O*-acetyl-α-[d]{.smallcaps}-galactopyranosyl bromide (822 mg, 2.0 mmol), Cs~2~CO~3~ (391 mg, 1.2 mmol), and Na~2~SO~4~ (284 mg, 2.0 mmol) in dimethylformamide (DMF; 30 mL) was stirred for 12 h at room temperature. The reaction mixture was washed using AcOEt through a glass filter, and the filtrate was evaporated to remove the solvents. The residue was purified by column chromatography (AcOEt/*n*-hexane = 1:2), and then the product was recrystallized from Et~2~O to obtain pure product **3** as a white solid (170 mg, 70% yield). ^1^H NMR (500 MHz, CDCl~3~) δ 1.82 (s, 3H), 2.03 (s, 3H), 2.15 (s, 3H), 2.24 (s, 3H), 4.21--4.25 (m, 3H), 5.16 (dd, *J* = 3.7, 10.3 Hz, 1H), 5.33 (d, *J* = 8.1 Hz, 1H), 5.51 (d, *J* = 3.5 Hz, 1H), 5.74 (dd, *J* = 8.1, 10.3, 1H), 7.24 (dd, *J* = 2.0, 8.6 Hz, 1H), 7.29 (d, *J* = 2.0 Hz, 1H), 7.41 (dt, *J* = 1.0, 7.1 Hz, 1H), 7.51 (dt, *J* = 1.2, 7.1 Hz, 1H), 7.93 (d, *J* = 8. 1 Hz, 1H), 8.08 (d, *J* = 8.1 Hz, 1H), 8.47 (d, *J* = 8.6 Hz, 1H); ^13^C NMR (125 MHz, CDCl~3~) δ 20.5, 20.7, 20.7, 61.9, 67.0, 68.5, 71.3, 71.9, 99.1, 115.7, 121.3, 122.0, 123.0, 123.7, 125.1, 126.2, 130.9, 136.0, 137.1, 152.0, 1524.4, 161.4, 169.3, 170.0, 170.2, 170.5; HRMS (FAB) *m*/*z* calcd for C~27~H~26~ClNO~10~S \[M + H\]^+^ 592.1044, found 592.1046.

### CBT-β-Gal (**4**) {#sec4.4.3}

Methanol solution of 7 N NH~3~ (540 μL) was added to a solution of the precursor (**3**) (211 mg, 0.35 mmol) in MeOH (6 mL). The mixture was stirred overnight at 45 °C. The reactions were monitored by TLC at regular intervals of time. After completion of hydrolysis, the solvent was removed under reduced pressure. The residue was purified by flash column chromatography (AcOEt/MeOH = 1:8) to obtain the product as a white solid (135 mg, 91%). ^1^H NMR (500 MHz, DMSO-*d*) δ 3.37--3.58 (m, 4H), 3.75--3.78 (m, 1H), 3.91--3.96 (m, 1H), 4.67 (d, *J* = 4.7 Hz, O*H*), 4.76 (t, *J* = 5.4 Hz, 1H), 5.01 (d, *J* = 5.9 Hz, 1H), 5.24 (d, *J* = 5.9 Hz, 1H), 5.27 (d, *J* = 7.6 Hz, 1H), 7.28 (dd, *J* = 2.0, 8.6 Hz, 1H), 7.44--7.47 (m, 2H), 7.54 (dt, *J* = 1.0, 8.1 Hz, 1H), 8.06 (d, *J* = 8.1 Hz, 1H), 8.10 (d, *J* = 7.8 Hz, 1H), 8.44 (d, *J* = 8.6 Hz, 1H); ^13^C NMR (125 MHz, DMSO-*d*) δ 60.4, 68.1, 70.1, 73.5, 75.9, 101.0, 115.3, 120.8, 121.8, 122.2, 122.6, 125.2, 126.4, 130.1, 135.8, 136.4, 151.5, 155.3, 161.6; HRMS (FAB) *m*/*z* calcd for C~19~H~18~ClNO~6~S \[M + H\]^+^ 424.0622, found 424.0622.

General Procedure for the UV/Vis Fluorescence Experiments {#sec4.5}
---------------------------------------------------------

UV--visible and fluorescence spectra were measured using a Shimadzu RF-1500 spectrophotometer. Probe **1a**, HBT, CBT-β-Gal, and CBT were dissolved in DMF to make a stock solution (10 mM). The spectroscopic experiments were performed in solution (DMSO/PBS = 1:1000, v v^--1^). The fluorescence emission spectra were recorded at 470 and 510 nm, with 365 nm as the excitation wavelength.

Selectivity of Probe **1a** toward Superoxide Anion (O~2~^--^), Hydroxyl Radical (^•^OH), and Hydrogen peroxide (H~2~O~2~) {#sec4.6}
--------------------------------------------------------------------------------------------------------------------------

Selectivity experiments were performed according to previous studies.^[@ref30],[@ref31]^ H~2~O~2~, NaClO, *t*BuOOH, and NaNO~2~ were prepared for a 4 mM solution in water. To a 96-well plate, the ROS solution (50 μL) and probe **1a** (2 μL, 10 mM solution in dimethyl sulfoxide (DMSO)) were added. The final solution volume was adjusted to 200 μL with PBS buffer, resulting in a final concentration of ROS (1 mM, 5 equiv) and probe **1a** (200 μM). The reaction of 2,2′-azobis(-amidinopropane) dihydrochloride (109 mg) and *tert*-butanol (36 mg) in PBS buffer (10 mL) generated *t*BuOO^•^ species. ^•^OH was generated by a Fenton reaction. A mixture of H~2~O~2~ (51 μL, 30% in water) and Fe(SO~4~)~2~·7H~2~O (139 mg) in 10 mL of PBS buffer solution was prepared. O~2~^--^ was from KO~2~ (47 mg) in anhydrous DMSO (1 mL). The suspension was diluted to 9 mL of buffer solution, and 4 μL of the solution was immediately transferred to a solution of PBS buffer (194 μL) and probe **1a** (2 μL, 10 mM solution in DMSO). The 96-well plate was incubated at 30 °C for 120 min. The fluorescence intensity was recorded at 470 and 510 nm with 365 nm as the excitation wavelength using a multiplate reader, BioTek Cytation 3.

WST-1 Assay {#sec4.7}
-----------

To perform cytotoxicity testing, the HeLa cells (5 × 10^3^ per well) were seeded in a 96-well plate and incubated at 37 °C overnight. The cells were treated using 100 μL of Dulbecco's modified Eagle's medium (DMEM) containing varying concentrations of probe **1a** or CBT-β-Gal and incubated for 24 h. Subsequently, 10 μL per well of the cell proliferation reagent WST-1 (Roche, Germany) was added to the cells and further incubated at 37 °C for 30 min. The absorbance was measured at 450 nm using a reference wavelength of 600 nm in a TECAN Infinite M200 microplate reader. The relative cell viability in the treated cells was calculated with respect to the untreated cells.

Bioimaging with Probe **1a** for Exogenous H~2~O~2~ in Living Cells {#sec4.8}
-------------------------------------------------------------------

The HeLa cells were seeded in a 24-well plate and allowed to adhere overnight before treatment. The HeLa cells were incubated in DMEM at 37 °C in a humidified atmosphere containing 5% CO~2~. After washing the cells with PBS (pH = 7.4), the cells were incubated with **1a** (50 μM) for 30 min. Then, the cells were treated with H~2~O~2~ (200 or 400 μM) and further incubated for 120 min. After washing the cells with PBS (pH = 7.4), fluorescence images were obtained using a fluorescence microscope.

Bioimaging with CBT-β-Gal for β-Galactosidase Activity in Living Cells {#sec4.9}
----------------------------------------------------------------------

The HeLa cells or Madin--Darby canine kidney cells were plated at a density of 1 × 10^5^ cells per well into a 24-well plate. After incubation for 24 h to allow the cells to adhere, the medium was removed, and the cells were washed with PBS. Then, the cells were incubated with CBT-β-Gal (12.5, 25, 50, 100 μM) in DMEM at 37 °C and 5% CO~2~ for 24 h. Next, the cells were thoroughly washed three times with PBS and cell fluorescence images were obtained using a fluorescence microscope (see [Figure S8](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b04208/suppl_file/ao9b04208_si_001.pdf)).

Bioimaging with CBT-β-Gal for H~2~O~2~-Induced β-Galactosidase Activity in Living Cells {#sec4.10}
---------------------------------------------------------------------------------------

The HeLa cells seeded in a 24-well plate were incubated in DMEM at 37 °C and 5% CO~2~ for 24 h. After washing the cells with PBS buffer (pH = 7.4), the cells were treated with H~2~O~2~ (200 μM) for 2 h. Then, the cells were washed again with PBS and incubated with CBT-β-Gal (12.5 μM) or SPiDER-βGal (1.0 μM) for 24 h. Cell imaging was then performed after washing with PBS (pH = 7.4). Cell fluorescence images were obtained using a fluorescence microscope. For SPiDER-βGal (*E*~x~: 525--545 nm, *E*~m~: 605--670 nm).

Bioimaging of ROS and β-Galactosidase Activity in Dox-Treated Cells {#sec4.11}
-------------------------------------------------------------------

The HeLa cells seeded in a 24-well plate were incubated for 24 h before treatment. The cells were washed with PBS (pH = 7.4), treated with Dox (100 nM), and further incubated for 24 h. After washing the cells with PBS buffer (pH = 7.4), the cells were incubated with **1a** (50 μM), probe **4** (12.5 μM), or SPiDER-βGal (1.0 μM) for 30 min. The cells were washed with PBS buffer (pH = 7.4), and images were obtained using a fluorescence microscope.

The Supporting Information is available free of charge at [https://pubs.acs.org/doi/10.1021/acsomega.9b04208](https://pubs.acs.org/doi/10.1021/acsomega.9b04208?goto=supporting-info).General experimental procedures and characterization data for the probes; fluorescence spectral changes of probes **1a--e** after the addition of H~2~O~2~; UV--vis absorption and emission spectra; fluorescence images of endogenous ROS in HeLa cells; fluorescence images of endogenous β-galactosidase in HeLa and MDCK cells; NMR spectra of **1a** and compounds **2**--**4** ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b04208/suppl_file/ao9b04208_si_001.pdf))
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